Paul C. Grint
Overview
Paul C. Grint received an average of $559K in total compensation, including $376K in salary, at AmpliPhi Biosciences between 2017 and 2018. Paul Grint also received an average of $3M at Regulus Therapeutics from 2014 to 2017.
- 2018
- 2017
- 2016
- 2015
- 2014
AmpliPhi BiosciencesFormer Chief Executive Officer
Regulus TherapeuticsFormer President and Chief Executive Officer
AmpliPhi BiosciencesFormer Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Regulus TherapeuticsPresident & Chief Executive Officer
Source: SEC filings on October 22, 2019, April 20, 2018, April 28, 2017, and April 22, 2016.
Related executives
We found 25 more executives who work or worked at AmpliPhi Biosciences and Regulus Therapeutics.
Joseph Hagan
Regulus Therapeutics
Chief Executive Officer
Brian Varnum
AmpliPhi Biosciences
Chief Executive Officer
Todd Patrick
AmpliPhi Biosciences
Chief Executive Officer
Christopher Aker
Regulus Therapeutics
General Counsel
Steve Martin
AmpliPhi Biosciences
Chief Financial Officer
Cris Calsada
Regulus Therapeutics
Chief Financial Officer
Daniel Chevallard
Regulus Therapeutics
Chief Financial Officer
Timothy Wright
Regulus Therapeutics